NMRK2 and cancer: Our proteomics results demonstrated a reduction in the expression of proteins implicated in OXPHOSome, a finding further corroborated by measurements pinpointing dysregulated NAD+ metabolism and alterations in NAD+ biosynthesis including downregulation of Nrk2 in cancer cachexia.